Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection;Coriorretinopatía serosa central como manifestación extradigestiva de infección gástrica por Helicobacter pylori

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 83, Issue 3, 2008, Pages 177-181

  Asensio Sanchez V M ^a   Rodriguez Delgado B ^a   Garcia Herrero E ^a   Cabo Vaquera, V ^a   Garcia Loygorri C ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

CSC; Extradigestive manifestation; Gastric infection; Helicobacter pylori; Risk factor; Urea breath test

Indexed keywords

ARTICLE; CHOROID DISEASE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; RETINA DISEASE;

CHOROID DISEASES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RETINAL DISEASES;

EID: 42949083632     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lamkin JC, Singerman LJ, Addiego R. Laser treatment of macular diseases. In: Grossniklaus HE, Kincaid MC. Ophthalmology Clinics of North America. Macular Diseases. Philadelphia: Saunders; 1993; 317-337.
2. Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 1995; 102: 737-747.
3. Keltikangas-Jarvinen L. The prevalence and construct validity of type A behaviour in patients with duodenal ulcers. Br J Med Psychol 1987; 60: 163-167.
4. Anto T, Goto Y, Maeda O, Watanabe O, Ishiguro K, Goto H. Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol 2006; 12: 181-186.
5. Gobbo AC, de Freitas M, Cury PM, Caetano A, Borim AA, Silva AE. Genetic alterations in benign lesions: chronic gastritis and gastric ulcer. World J Gastroenterol 2006; 12: 625-629.
6. Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori. Minerva Med 2006; 97: 39-45.
7. Nilsson HO, Pietroiusti A, Gabrielli M, Zocco MA, Gasbarrini G, Gasbarrini A. Helicobacter pylori and extragastric diseases - other Helicobacters. Helicobacter 2005; 10: 54-65.
8. Gabrielli M, Santoliquido A, Cremonini F, Cicconi V, Candelli M, Serricchio M, et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. Eur Heart J 2004; 25: 64-68.
9. Gabrielli M, Pola P, Gasbarrini A. Helicobacter pylori, CagA-positive strains, and ischemic stroke. Stroke 2002; 33: 1453-1454.
10. Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Torres ES, et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999; 45: I9-I12.
11. Mindel JS, Rosenberg EW. Is Helicobacter pylori of interest to ophthalmologists? Ophthalmology 1997; 104: 1729-1730.
12. Franceschi F, Gasbarrini A, Fontana L. Role of Helicobacter pylori infection in ophthalmology. Ophthalmology 1998; 105: 1351-1352.
13. Sacca SC, Pascotto A, Venturino GM, Prigione G, Mastromarino A, Baldi F, et al. Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci 2006; 47: 501-508.
14. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S; Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004; 111: 244:249.
15. Allibhai ZA, Gale JS, Sheidow TS. Central serous chorioretinopathy in a patient taking sildenafil citrate. Ophthalmic Surg Lasers Imaging 2004; 35: 165-167.
16. Cunningham ET Jr, Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 1996; 103: 2081-2090.
17. Iijima H, Iida T, Murayama K, Imai M, Gohdo T. Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Am J Ophthalmol 1999; 127: 477-478.
18. Mauget-Faysse M, Kodjikian L, Quaranta M, Ben Ezra D, Trepsat C, Mion F, et al. Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study. J Fr Ophtalmol 2002; 25: 1021-1025.
19. Ahnoux-Zabsonre A , Quaranta M, Mauget-Faysse M. Prevalence of Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy: a complementary study. J Fr Ophtalmol 2004; 27: 1129-1133.
20. Giusti C. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. Med Hypotheses 2004; 63: 524-527.
21. Giusti C, Mauget-Faysse M. Helicobacter pylori and idiopathic central serous chorioretinopathy. Swiss Med Wkly 2004;134:395-398.
22. Logan RP, Walker MM. ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection. BMJ 2001; 323: 920-922.
23. Hooton C, Keohane J, Clair J, Azam M, O'Mahony S, Crosbie O, et al. Comparison of three stool antigen assays with the 13C- urea breath test for the primary diagnosis of Helicobacter pylori infection and monitoring treatment outcome. Eur J Gastroenterol Hepatol 2006; 18: 595-599.
24. de Martel C, Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci 20006; 51: 2292-2301.
25. Cotticelli L, Borrelli M, D'Alessio AC, Menzione M, Villani A, Piccolo G, et al. Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol 2006; 16: 274-278.
26. Logan RP, Berg DE. Genetic diversity of Helicobacter pylori. Lancet 1996; 348: 1462-1463.
27. Reche-Frutos J, Calvo-González C, Donate-López J, Sáenz-Francés-San-Baldomero F, Cerván-López I, García-Feijoó J, y col. Photodynamic therapy in severe chronic central serous chorioretinopaty. Arch Soc Esp Oftalmol 2008; 83: 9-14.
28. Niegel MF, Schrage NF, Christmann S, Degenring RF. Intravitreal bevacizumab for chronic central serous chorioretinopathy. Ophthalmologe 2008 Jan 24.